Marshall Miller, MD
![1]()
News
DOACs for treatment of cancer-associated venous thromboembolism
January 23, 2020
Recent studies suggest DOACs may be a viable option in the treatment of malignancy-associated VTE.
Recent studies suggest DOACs may be a viable option in the treatment of malignancy-associated VTE.
